Boris Ceh

Title: Boris Ceh - Innovator in Microbial Treatment for Inflammatory Bowel Disease

Introduction

Boris Ceh is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of microbiology, particularly in the treatment of inflammatory bowel disease. His innovative approach involves the use of modified food-grade microorganisms that can effectively bind to TNFα, a key player in inflammatory processes.

Latest Patents

Boris Ceh holds a patent for a "Modified food grade microorganism for treatment of inflammatory bowel disease." This invention relates to microorganisms that express or have attached to their surface a TNFα binding polypeptide. The microorganisms are designed to be more resistant to chemical and enzymatic degradation in the gastrointestinal tract. By binding TNFα, these microorganisms can reduce the content of free TNFα, thereby alleviating its pro-inflammatory effects in the gut. This invention also highlights the potential use of such microorganisms as a medicament in treating inflammatory bowel disease.

Career Highlights

Throughout his career, Boris Ceh has been associated with prestigious institutions such as the University of Ljubljana and the Institute Jozef Stefan. His work has focused on the intersection of microbiology and medicine, leading to advancements that could improve the quality of life for individuals suffering from inflammatory bowel disease.

Collaborations

Boris has collaborated with notable colleagues, including Mojca Lunder and Matjaz Ravnikar. Their combined expertise has contributed to the development and refinement of his innovative approaches in microbial treatments.

Conclusion

Boris Ceh's work exemplifies the potential of innovative microbial solutions in addressing complex health issues like inflammatory bowel disease. His contributions to the field are paving the way for new therapeutic options that could significantly benefit patients.